Director
CurrentDirector, Equity Investment & Strategy Group (2024-Present)- Achieved 23% absolute return and 157bps excess return versus MSCI ACWI in 2023, enhancing the performance of the Balancing Fund (AUM $3B) and Completion Fund, which led to promotion to Director; Delivered 6.83% return in first half of 2024- Executed alpha and beta hedging strategies to manage cash flows across multiple internal equity fundsSenior Manager, Equity Investment & Strategy; Asset Allocation Group; Human Resources Development Group (2017-2024)- Generated 44% absolute return from Jan 2021 to Dec 2023 by managing Balancing Fund that engages in global equity long/short strategies with equities and equity derivatives- Traded Completion Fund to close gap between KIC’s actual equity portfolio (AUM: $US81bn) and benchmark index- Researched and presented global macroeconomic trends every week to develop macro-investment strategies; co-managed cross-asset investments for Tactical Asset Allocation Fund (AUM: US$3bn); - Developed sector and company reports for the Global Core Fund (AUM $20B), featuring comprehensive investment theses; co-led stock selection; identified long-term outperformers against benchmarks.- Designed and implemented training programs, including new-employee orientation and managerial-level trainingAssociate, Equity Research Group; Corporate Planning & Coordination Group (2012-2017)- Constructed model portfolios for EU & US Consumer Staples and Asia Health Care (combined market cap: US$4.1trn, 176 companies) by rating companies based on in-depth analysis; Published sector and company reports for investment committee- Published reports on performances and strategies of KIC to present to the stakeholders of KIC, including National Congress of Korea and Bank of Korea; Attended regular and ad hoc parliamentary sessions of KIC
